Cancer Forums and News by PhD's


News | Forums Register

Go Back   Cancer Forums and News by PhD's > Leukemia Forum > Chronic Lymphocytic Leukemia

Reply
 
Thread Tools Display Modes
  #1  
Old 06-05-2008, 10:29 AM
Dross Dross is offline
Moderator
 
Join Date: Nov 2006
Posts: 883
Default Clinical study shows biological and clinical activity in relapsed leukemia patients

A new story entry has been added:

Clinical study shows biological and clinical activity in relapsed leukemia patients

Quote:
LUGANO, SWITZERLAND, June 4, 2008 ? Finbarr Cotter, M.D., Ph.D., Professor of the Institute of Cell and Molecular Science at Barts and The London School of Medicine, today presented in an oral session "Clinical Caspase Activation in CLL by GCS-100: a Phase 2 Study" at the 10th International Conference on Malignant Lymphoma (10-ICML). The promising interim results from this ongoing clinical trial indicate that single-agent GCS-100 induces apoptosis (programmed cell death) in patients' CLL cells, reduces leukocyte count in some patients and is generally well tolerated. GCS-100 targets galectin-3, a protein over-expressed in cancer cells that promotes their survival, proliferation and metastasis.
Reply With Quote
Sponsored Links
Advertisement
Reply


Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -5. The time now is 04:18 AM.